Literature DB >> 34109485

Brain connectivity markers in advanced Parkinson's disease for predicting mild cognitive impairment.

Hai Lin1,2,3, Zesi Liu1,4, Wei Yan5, Doudou Zhang1,3, Jiali Liu1,3, Bin Xu1,3, Weiping Li1,2,3, Qiusheng Zhang6,7, Xiaodong Cai8,9.   

Abstract

OBJECTIVES: Mild cognitive impairment (MCI) is a well-defined non-motor manifestation and a harbinger of dementia in Parkinson's disease. This study is to investigate brain connectivity markers of MCI using diffusion tensor imaging and resting-state functional MRI, and help MCI diagnosis in PD patients.
METHODS: We evaluated 131 advanced PD patients (disease duration > 5 years; 59 patients with MCI) and 48 healthy control subjects who underwent a diffusion-weighted and resting-state functional MRI scanning. The patients were randomly assigned to training (n = 100) and testing (n = 31) groups. According to the Brainnetome Atlas, ROI-based structural and functional connectivity analysis was employed to extract connectivity features. To identify features with significant discriminative power for patient classification, all features were put into an all-relevant feature selection procedure within cross-validation loops.
RESULTS: Nine features were identified to be significantly relevant to patient classification. They showed significant differences between PD patients with and without MCI and positively correlated with the MoCA score. Five of them did not differ between general MCI subjects and healthy controls from the ADNI database, which suggested that they could uniquely play a part in the MCI diagnosis of PD. On basis of these relevant features, the random forest model constructed from the training group achieved an accuracy of 83.9% in the testing group, to discriminate patients with and without MCI.
CONCLUSIONS: The results of our study provide preliminary evidence that structural and functional connectivity abnormalities may contribute to cognitive impairment and allow to predict the outcome of MCI diagnosis in PD. KEY POINTS: • Nine MCI markers were identified using an all-relevant feature selection procedure. • Five of nine markers differed between MCI and NC in PD, but not in general persons. • A random forest model achieved an accuracy of 83.9% for MCI diagnosis in PD.

Entities:  

Keywords:  Cognition disorders; Diffusion tensor imaging; Magnetic resonance imaging; Parkinson disease

Year:  2021        PMID: 34109485     DOI: 10.1007/s00330-021-08086-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  47 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

2.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

Authors:  Rafael González-Redondo; David García-García; Pedro Clavero; Carmen Gasca-Salas; Reyes García-Eulate; José L Zubieta; Javier Arbizu; José A Obeso; María C Rodríguez-Oroz
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

3.  Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.

Authors:  Yuto Uchida; Hirohito Kan; Keita Sakurai; Nobuyuki Arai; Daisuke Kato; Shoji Kawashima; Yoshino Ueki; Noriyuki Matsukawa
Journal:  Mov Disord       Date:  2019-05-15       Impact factor: 10.338

4.  Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.

Authors:  Joana B Pereira; Dag Aarsland; Cedric E Ginestet; Alexander V Lebedev; Lars-Olof Wahlund; Andrew Simmons; Giovanni Volpe; Eric Westman
Journal:  Hum Brain Mapp       Date:  2015-05-06       Impact factor: 5.038

5.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

6.  Defining mild cognitive impairment in Parkinson's disease.

Authors:  John N Caviness; Erika Driver-Dunckley; Donald J Connor; Marwan N Sabbagh; Joseph G Hentz; Brie Noble; Virgilio Gerald H Evidente; Holly A Shill; Charles H Adler
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

7.  Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging.

Authors:  Lei Wu; Feng-Tao Liu; Jing-Jie Ge; Jue Zhao; Yi-Lin Tang; Wen-Bo Yu; Huan Yu; Tim Anderson; Chuan-Tao Zuo; Ling Chen; Jian Wang
Journal:  Hum Brain Mapp       Date:  2018-07-12       Impact factor: 5.038

8.  Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.

Authors:  Zhen Fan; Yahyah Aman; Imtiaz Ahmed; Gaël Chetelat; Brigitte Landeau; K Ray Chaudhuri; David J Brooks; Paul Edison
Journal:  Alzheimers Dement       Date:  2014-09-16       Impact factor: 21.566

9.  Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Brain       Date:  2015-07-14       Impact factor: 13.501

Review 10.  Dopamine receptor mapping with PET imaging in Parkinson's disease.

Authors:  Flavia Niccolini; Paul Su; Marios Politis
Journal:  J Neurol       Date:  2014-03-15       Impact factor: 4.849

View more
  1 in total

1.  Neural synchronization analysis of electroencephalography coherence in patients with Parkinson's disease-related mild cognitive impairment.

Authors:  Tomoo Mano; Kaoru Kinugawa; Maki Ozaki; Hiroshi Kataoka; Kazuma Sugie
Journal:  Clin Park Relat Disord       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.